Search for a command to run...
Study readouts, meta-analyses, and preclinical findings across the peptide literature, summarized with links to primary sources.
A single investigational molecule engages three metabolic hormone receptors at once. Here is what the New England Journal of Medicine data actually showed, and what it does not.
A landmark outcomes study asked whether a GLP-1 peptide prevents heart attacks and strokes, not just weight. The 17,604-person answer reshaped how the class is viewed.
The pivotal obesity trial for tirzepatide reset expectations for what a single injectable peptide could achieve. A look at the actual numbers, endpoints, and caveats.